NJACS - Organic Chemistry Group

NJ-ACS Organic Topical Group – Past Meetings

Meetings: [ current | past ]

Past Meetings

August 13, 2009 – Symposium and Celebration

‘A Celebration of Organic Synthesis’
to mark the 65th Birthday of
Prof. Amos B. Smith III

Keynote Speaker:

Professor Amos B. Smith III

Thursday August 13, 2009

Rutgers, Busch Campus
Science and Engineering Resource Center
118 Frelinghuysen Rd, Piscataway, NJ 08854

[ Directions & Parking | Registration (below) | Flyer ]

Registration fee: $100.00 (Symposium, & Lunch)

Registration	8:30 AM
Symposium	9:00 AM
Lunch	12:00 noon

Please register according to the instruction below

Invited Speakers

John L Wood I. “Bridged Polycyclic Natural Products: Inspirational Targets for Total Synthesis”

Professor John L Wood (Colorado State University)

Karl Hale II. “Total Synthesis of Azinothricin and Kettapeptin and Allied Chemical Genomics Studies on the A83586C Class of Antitumor Antibiotics”

Professor Karl Hale (Queen's University, Belfast)

Jon D. Rainier III. “Complex Molecule Synthesis” (tentative)

Professor Jon D. Rainier (University of Utah)

Matthew Gaunt IV. “New catalytic Strategies for Chemical Synthesis”

Professor Matthew Gaunt (University of Cambridge)

Gary A. Sulikowski V. “Studies Directed Toward the Synthesis of Natural Products”

Professor Gary A. Sulikowski (Vanderbilt University)

Amos B. Smith III VI. “Evolution of Anion Relay Chemistry (ARC): Construction of Architecturally Complex Natural and Unnatural Products”

Professor Amos B. Smith III (University of Pennsylvania) – Keynote Address

Thursday November 13, 2008

The Award for Creativity in Molecular Design and Synthesis

2008 Award Recipient:

Dr. Malcolm MacCoss

Thursday November 13, 2008

Palace at Somerset Park, 333 Davidson Ave, Somerset, NJ 08873

[ Directions | Flyer ]

Registration fee: $125.00 (Symposium, Reception & Dinner)
Students & Post-Docs: $100.00

Registration	12:00 noon
Symposium	1:00 p.m.
Reception	5:45 p.m.
Dinner	6:30 p.m.
Awards Address	7:30 p.m.

Invited Speakers

David Evans I.
“Three Decades of Research on Stereochemical Control”

Professor David Evans (Harvard University)

David MacMillan II.
“New Catalysis Concepts”

Professor David MacMillan (Princeton University)

Sandy Mills III.
“Discovery of Second Generation NK-1 Antagonists”

Dr. Sandy Mills (Merck & Co, Inc.)

Dean Toste IV.
“Catalysis via Cationic Intermediate”

Professor Dean Toste (University of California, Berkeley)

Barry Trost V.
“A Challenge for Total Synthesis: Atom Economy”

Professor Barry Trost (Stanford University)

Malcolm MacCoss VI.
“A Career In Chemistry And Medicinal Chemistry: Some Personal Reflections On One Path Taken”

Dr. Malcolm MacCoss (Schering-Plough Research Inst.)

May 2008 Meeting and Symposium

Pharmaceutical Success Stories

Thursday May 22, 2008

Palace at Somerset Park, 333 Davidson Ave, Somerset, NJ 08873

[ Directions ]

Registration fee: $95.00 (Symposium and Lunch)

Registration	8:30 a.m.
Symposium	9:00 a.m. – 4:30 p.m.
Lunch	12:30 p.m.

Invited Speakers

I.
“Process Chemistry at GlaxoSmithKline, The Development of a Manufacturing Route to a Cathepsin K Inhibitor”

William Clark & Robert W. Marquis (GlaxoSmithKline)

II.
“Discovery and Development of SGLT-2 Inhibitors”

Prashant Desphande & Wei Meng (Bristol Myers Squibb)

III.
“Natural Products in Drug Discovery: The Development of Cancidas®”

James Balkovec (Merck Research Laboratories)

IV.
“From R1479 to R1626: Discovery and Advancement of 4’-Substituted Nucleosides for the Treatment of Hepatitis C”

David Smith (Roche)

V.
“The Discovery of Varenicline, a Nicotinic Receptor Partial Agonist for Smoking Cessation”

Jotham Coe (Pfizer)

Drugs from Academia: Marketed Drugs from Academic Labs

Friday, October 26, 2007

Palace at Somerset Park, 333 Davidson Ave, Somerset, NJ 08873

[ Directions ]

Registration fee: $95.00 (Symposium and Lunch)

Registration	8:30 a.m.
Symposium	9:00 a.m. – 4:30 p.m.
Lunch	12:30 p.m.

Invited Speakers

I.
“Discovery of Alimta, a Broadly Effective New Antitumor Agent”

Edward C. Taylor (Princeton University)

II.
“SAHA (Vorinostat): The First Anticancer HDAC Inhibitor Approved for Human Use”

Ronald Breslow (Columbia University)

III.
“Didanosine (ddI): A Member of the Versatile 2',3'-Dideoxy Family of Biomedicinal Nucleoside Analogues”

Morris J. Robins (Brigham Young University)

IV.
“Basic Science to the Market. The Discovery of Lyrica®”

Richard B. Silverman (Northwestern University)

V.
“The Discovery of 3TC and FTC”

Dennis C. Liotta (Emory Uinversity)

May 24 2007 Meeting and Symposium
[ Group Photo ]

New Methods and Strategies for Heterocyclic Synthesis

Thursday, May 24, 2007

Invited Speakers

I.
"Strategies for the Synthesis of Heterocyclic Natural Products"

Stephen F. Martin (University of Texas, Austin)

II.
"Chemoenzymatic Synthesis of Alkaloids: A Multi-Generational Approach"

Tomas Hudlicky (Brock University, St. Catharines, Ontario, Canada)

III.
"A Conducted Tour of Recent Heteroaromatic Directed ortho Metalation"

Victor Snieckus (Queen's University, Kingston, Ontario, Canada)

IV.
"Synthesis of Heterocycles via Transition Metal-Mediated Catalysis"

Chulbom Lee (Princeton University)

V.
"Cascade Reaction in Complex Alkaloid Synthesis"

Mohammad Movassaghi (MIT)

Speakers and Section Officers at the May 2007 Symposium

From left to right: Dr. Binh Vu, Prof. Victor Snieckus, Prof. Lawrence Williams Prof. Steve Martin, Prof. Chulbom Lee, Dr. Albert DelMonte, Prof. Mo Movassaghi, Dr. Amjad Ali, Dr. Gabor Butora, Dr. Dong Xiao, Prof. Tomas Hudlicky.

Friday, November 17, 2006

Discovery, Selection, and Development of Drug Candidates:
A Senior Leadership Perspective

[ photos ]

Poster - Click to enlarge

Speakers:

Keynote Address:
Dr. P. Roy Vagelos (Retired Chairman and CEO, Merck & Co., Inc.)
“The Changing Pharmaceutical Industry”

Dr. Carl Decicco (Bristol-Myers Squibb)
“Innovation in Drug Discovery”

Dr. Paul Feldman (GlaxoSmithKline)
“PPAR Pan Agonists-The Next Generation PPAR Ligands”

Dr. Malcolm MacCoss (Merck)
“EMEND(c) (Aprepitant) a potent, orally active Substance P Antagonist for the treatment of Chemotherapy Induced Nausea and Vomiting (CINV), from the medicinal chemistry bench to the clinic”

Dr. Bruce Roth (Pfizer)
“The Discovery and Development of Lipitor”

Registration Form (pdf)

Location
Somerset Marriott
110 Davidson Avenue
Somerset, New Jersey 08873
(Directions)

This event involved 4 Vice Presidents in charge of research at 4 of the largest Pharma compan ies in the US. The evening ended with a keynote talk by Dr. P. Roy Vagelos (retired Chariman and CEO, Merck).

(Click pictures to enlarge)

Dr. P. Roy Vagelos provides Keynote Address

Drs. Paul Feldman, Malcolm MacCoss, Bruce Roth, Carl Decicco, and 2006 OTG Committee